Last updated: 2026-09-05 18:44:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
China SXT Pharmaceuticals, Inc. (SXTC) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $2,27, with a market capitalisation of $1,19M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2,06 to $83 758,80. This page covers its latest market performance, valuation, price trends and company information.
$1,19M | |
$2,23 | |
$4 483 200 000,00 | |
$2,06 | |
$2,20 | |
38,70K | |
-- | |
-- | |
$83 758,80 | |
$2,06 | |
-- | |
-- |
China SXT Pharmaceuticals, Inc. (SXTC) last closed at $2,20 as of 2026-09-04 23:59:00, unchanged from the previous close of $2,20.
During the latest regular trading session, SXTC traded between $2,06 and $4 483 200 000,00, with a volume of 38,70K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, China SXT Pharmaceuticals, Inc. (SXTC) moved from $3,03 to $2,27, representing a decline of 25,12% ($0,76).
The stock traded between $2,19 and $2,37 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 107,30 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0,0%
SXTC is currently trading at $2,27, placing it 0,0% of the way from its 52-week low of $2,06 to its 52-week high of $83 758,80. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly TCMP (Directed-oral TCMP and After-soaking TCMP), which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
| Employees | 56 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of China SXT Pharmaceuticals, Inc. (SXTC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.